JPY2,218.50
4.67% today
Tokyo, Apr 04, 08:15 am CET
ISIN
JP3256000005
Symbol
4151
Index
Sector
Industry

Kyowa Kirin Stock price

JPY2,204.00
+35.00 1.61% 1M
-422.00 16.07% 6M
-171.50 7.22% YTD
-412.00 15.75% 1Y
-686.00 23.74% 3Y
-143.00 6.09% 5Y
+572.00 35.05% 10Y
Tokyo, Closing price Fri, Apr 04 2025
+84.50 3.99%
ISIN
JP3256000005
Symbol
4151
Index
Sector
Industry

Key metrics

Market capitalization JPY1.11t
Enterprise Value JPY886.25b
P/E (TTM) P/E ratio 18.78
EV/FCF (TTM) EV/FCF 21.18
EV/Sales (TTM) EV/Sales 1.79
P/S ratio (TTM) P/S ratio 2.24
P/B ratio (TTM) P/B ratio 1.30
Dividend yield 2.83%
Last dividend (FY25) JPY60.00
Revenue growth (TTM) Revenue growth 12.06%
Revenue (TTM) Revenue JPY495.56b
EBIT (operating result TTM) EBIT JPY91.87b
Free Cash Flow (TTM) Free Cash Flow JPY41.85b
Cash position JPY244.68b
EPS (TTM) EPS JPY112.84
P/E forward 19.38
P/S forward 2.31
EV/Sales forward 1.84
Show more

Is Kyowa Kirin a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Kyowa Kirin Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Kyowa Kirin forecast:

4x Buy
40%
6x Hold
60%

Analyst Opinions

10 Analysts have issued a Kyowa Kirin forecast:

Buy
40%
Hold
60%

Financial data from Kyowa Kirin

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
495,557 495,557
12% 12%
100%
- Direct Costs 138,590 138,590
14% 14%
28%
356,967 356,967
11% 11%
72%
- Selling and Administrative Expenses 136,778 136,778
4% 4%
28%
- Research and Development Expense 103,544 103,544
44% 44%
21%
116,645 116,645
0% 0%
24%
- Depreciation and Amortization 24,780 24,780
17% 17%
5%
EBIT (Operating Income) EBIT 91,865 91,865
4% 4%
19%
Net Profit 59,869 59,869
26% 26%
12%

In millions JPY.

Don't miss a Thing! We will send you all news about Kyowa Kirin directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It operates through the Pharmaceuticals and Bio-Chemicals segments. The Pharmaceuticals segment deals with the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. The Bio-Chemicals segment produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Masashi Miyamoto
Employees 5,669
Founded 1949
Website www.kyowakirin.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today